Format
Items per page
Sort by

Send to:

Choose Destination

Results: 15

Related Articles by Review for PubMed (Select 16959574)

1.

TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth.

Inoki K, Ouyang H, Zhu T, Lindvall C, Wang Y, Zhang X, Yang Q, Bennett C, Harada Y, Stankunas K, Wang CY, He X, MacDougald OA, You M, Williams BO, Guan KL.

Cell. 2006 Sep 8;126(5):955-68.

2.

LKB1 and AMP-activated protein kinase control of mTOR signalling and growth.

Shaw RJ.

Acta Physiol (Oxf). 2009 May;196(1):65-80. doi: 10.1111/j.1748-1716.2009.01972.x. Epub 2009 Feb 19. Review.

3.

Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways.

Kwiatkowski DJ, Manning BD.

Hum Mol Genet. 2005 Oct 15;14 Spec No. 2:R251-8. Review.

4.

TSC2: filling the GAP in the mTOR signaling pathway.

Li Y, Corradetti MN, Inoki K, Guan KL.

Trends Biochem Sci. 2004 Jan;29(1):32-8. Review.

PMID:
14729330
5.

A complex interplay between Akt, TSC2 and the two mTOR complexes.

Huang J, Manning BD.

Biochem Soc Trans. 2009 Feb;37(Pt 1):217-22. doi: 10.1042/BST0370217. Review.

6.

Growth control under stress: mTOR regulation through the REDD1-TSC pathway.

Ellisen LW.

Cell Cycle. 2005 Nov;4(11):1500-02. Epub 2005 Nov 1. Review.

7.

The long and winding road to rational treatment of cancer associated with LKB1/AMPK/TSC/mTORC1 signaling.

van Veelen W, Korsse SE, van de Laar L, Peppelenbosch MP.

Oncogene. 2011 May 19;30(20):2289-303. doi: 10.1038/onc.2010.630. Epub 2011 Jan 24. Review.

PMID:
21258412
8.

Positive and negative regulation of TSC2 activity and its effects on downstream effectors of the mTOR pathway.

Jozwiak J, Jozwiak S, Grzela T, Lazarczyk M.

Neuromolecular Med. 2005;7(4):287-96. Review.

PMID:
16391386
9.

Wnt and beyond Wnt: multiple mechanisms control the transcriptional property of beta-catenin.

Jin T, George Fantus I, Sun J.

Cell Signal. 2008 Oct;20(10):1697-704. doi: 10.1016/j.cellsig.2008.04.014. Epub 2008 May 8. Review.

PMID:
18555664
10.

Role of AMP-activated protein kinase in cancer therapy.

Rehman G, Shehzad A, Khan AL, Hamayun M.

Arch Pharm (Weinheim). 2014 Jul;347(7):457-68. doi: 10.1002/ardp.201300402. Epub 2014 Mar 28. Review.

PMID:
24677093
11.

Rapamycin for treating Tuberous sclerosis and Autism spectrum disorders.

Ehninger D, Silva AJ.

Trends Mol Med. 2011 Feb;17(2):78-87. doi: 10.1016/j.molmed.2010.10.002. Epub 2010 Nov 4. Review.

12.

The AMP-activated protein kinase (AMPK) and cancer: many faces of a metabolic regulator.

Faubert B, Vincent EE, Poffenberger MC, Jones RG.

Cancer Lett. 2015 Jan 28;356(2 Pt A):165-70. doi: 10.1016/j.canlet.2014.01.018. Epub 2014 Jan 28. Review.

PMID:
24486219
13.

The Tsc1-Tsc2 complex influences neuronal polarity by modulating TORC1 activity and SAD levels.

Wildonger J, Jan LY, Jan YN.

Genes Dev. 2008 Sep 15;22(18):2447-53. doi: 10.1101/gad.1724108. Review.

14.

mTOR, translational control and human disease.

Tee AR, Blenis J.

Semin Cell Dev Biol. 2005 Feb;16(1):29-37. Epub 2004 Dec 31. Review.

PMID:
15659337
15.

[Function of tumor suppressor protein Mig-6 in growth signaling].

Kitagawa M.

Seikagaku. 2014 Aug;86(4):498-502. Review. Japanese. No abstract available.

PMID:
25255635
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk